Total Payments
$1,079
2024 Payments
$22.24
Companies
15
Transactions
50
Medicare Patients
1,829
Medicare Billing
$175,325
Payment Breakdown by Category
Food & Beverage$1,079 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,079 | 50 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $208.14 | 10 | $0 (2024) |
| ABBVIE INC. | $182.66 | 11 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $127.69 | 5 | $0 (2022) |
| Allergan Inc. | $113.54 | 1 | $0 (2017) |
| Lilly USA, LLC | $91.21 | 4 | $0 (2022) |
| Abbott Laboratories | $66.65 | 4 | $0 (2022) |
| GlaxoSmithKline, LLC. | $65.79 | 3 | $0 (2023) |
| ARBOR PHARMACEUTICALS, INC. | $58.65 | 3 | $0 (2021) |
| Amarin Pharma Inc. | $50.28 | 3 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $27.70 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.24 | 1 | Novo Nordisk Inc ($22.24) |
| 2023 | $52.51 | 2 | GlaxoSmithKline, LLC. ($32.22) |
| 2022 | $473.95 | 25 | ABBVIE INC. ($139.49) |
| 2021 | $397.24 | 20 | Novo Nordisk Inc ($68.17) |
| 2020 | $19.43 | 1 | Hologic, LLC ($19.43) |
| 2017 | $113.54 | 1 | Allergan Inc. ($113.54) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Diabetes | ||||||
| 11/14/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: PAIN | ||||||
| 06/29/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $32.22 | General |
| Category: RESPIRATORY | ||||||
| 08/03/2022 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Respiratory | ||||||
| 07/13/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $31.13 | General |
| Category: DIABETES | ||||||
| 07/11/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: Diabetes | ||||||
| 06/30/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: Diabetes | ||||||
| 06/22/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: PRIMARY CARE | ||||||
| 06/09/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: VACCINES | ||||||
| 06/03/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 05/31/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/19/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Diabetes Care | ||||||
| 05/18/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: DIABETES | ||||||
| 05/15/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Diabetes | ||||||
| 04/25/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.40 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Diabetes | ||||||
| 04/15/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: NEUROSCIENCE | ||||||
| 04/01/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: NEUROSCIENCE | ||||||
| 03/17/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 03/17/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 309 | 433 | $78,560 | $31,510 |
| 2022 | 7 | 300 | 441 | $78,980 | $34,038 |
| 2021 | 9 | 517 | 586 | $149,323 | $47,716 |
| 2020 | 16 | 703 | 977 | $209,163 | $62,061 |
Total Patients
1,829
Total Services
2,437
Medicare Billing
$175,325
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 50 minutes | Office | 2020 | 22 | 22 | $15,972 | $4,750 | 29.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 64 | 75 | $14,775 | $4,155 | 28.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 32 | 32 | $14,208 | $4,093 | 28.8% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 22 | 22 | $3,300 | $2,590 | 78.5% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 11 | 11 | $4,928 | $1,794 | 36.4% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 30 | 37 | $7,585 | $1,735 | 22.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 17 | 19 | $2,122 | $1,676 | 79.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 49 | 51 | $3,060 | $932.98 | 30.5% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 13 | 13 | $858.00 | $792.74 | 92.4% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 38 | 39 | $1,170 | $759.90 | 64.9% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 47 | 67 | $2,010 | $645.82 | 32.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 19 | 19 | $1,235 | $346.05 | 28.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 26 | 27 | $1,728 | $303.45 | 17.6% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 11 | 12 | $432.00 | $125.10 | 29.0% |
About Dr. Mamta Singh, M.D
Dr. Mamta Singh, M.D is a Geriatric Medicine healthcare provider based in Willimantic, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2012. The National Provider Identifier (NPI) number assigned to this provider is 1891031522.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mamta Singh, M.D has received a total of $1,079 in payments from pharmaceutical and medical device companies, with $22.24 received in 2024. These payments were reported across 50 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,079).
As a Medicare-enrolled provider, Singh has provided services to 1,829 Medicare beneficiaries, totaling 2,437 services with total Medicare billing of $175,325. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Medicine
- Location Willimantic, CT
- Active Since 12/28/2012
- Last Updated 04/02/2018
- Taxonomy Code 207RG0300X
- Entity Type Individual
- NPI Number 1891031522
Products in Payments
- QULIPTA (Drug) $121.74
- NAMZARIC (Drug) $113.54
- TRULICITY (Drug) $91.21
- Ozempic (Drug) $89.06
- Rybelsus (Drug) $75.91
- UBRELVY (Drug) $60.92
- Horizant (Drug) $58.65
- JARDIANCE (Drug) $53.00
- FreeStyle Libre (Device) $52.79
- Vascepa (Drug) $50.28
- NURTEC ODT (Drug) $47.99
- SPIRIVA RESPIMAT (Drug) $47.92
- RYBELSUS (Drug) $43.17
- SHINGRIX (Biological) $33.57
- AREXVY (Drug) $32.22
- TRADJENTA (Drug) $26.77
- Aptima Trichomonas (Device) $19.43
- Xofluza (Drug) $16.77
- TOUJEO (Biological) $15.95
- BEVESPI AEROSPHERE (Drug) $14.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.